ZVRA
Zevra Therapeutics, Inc.
$9.93+0.12 (1.22%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
6 of 40 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
KEMPHARM, INC (KMPH) is a publicly traded company with 23 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 7 unique insiders. All recorded transactions were sales totaling $-849K. Note that insider selling can occur for many reasons (diversification, tax planning, pre-scheduled 10b5-1 plans) and is not always a bearish signal. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 40 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | 2026-03-24 | Bode John B | Director | Exercise Conversion | 39,200 | $0.00 | $0 | N/A | N/A |
| 2026-03-26 | 2026-03-24 | Bode John B | Director | Exercise Conversion | 39,200 | $0.00 | $0 | N/A | N/A |
| 2026-03-26 | 2026-03-24 | Bode John B | Director | Exercise Conversion | 39,200 | $4.89 | $191,688 | N/A | N/A |
| 2026-03-26 | 2026-03-24 | Bode John B | Director | Exercise Conversion | 39,200 | $4.97 | $194,824 | N/A | N/A |
| 2026-03-19 | 2026-03-18 | Renz Justin A | CFO | Award | 300,000 | $9.55 | $2,865,000 | N/A | N/A |
| 2026-02-10 | 2026-02-09 | Mcfarlane Neil F. | CEO | Sale | 14,625 | $8.56 | $125,190 | N/A | N/A |
| 2026-02-10 | 2026-02-07 | Mcfarlane Neil F. | CEO | Exercise Conversion | 37,500 | $0.00 | $0 | N/A | N/A |
| 2026-02-02 | 2026-02-02 | Mcfarlane Neil F. | CEO | Sale | 91,000 | $9.38 | -$853,398 | N/A | N/A |
| 2026-02-02 | 2026-01-31 | Schafer Joshua | CCO | Exercise Conversion | 35,334 | $0.00 | $0 | N/A | N/A |
| 2026-02-02 | 2026-01-31 | Mcfarlane Neil F. | CEO | Exercise Conversion | 233,334 | $0.00 | $0 | N/A | N/A |
ZVRA
Director
Exercise Conversion
$191.7K
Bode John B39,200 shares @ $4.89
Filed 2026-03-26Trade 2026-03-24
ZVRA
Director
Exercise Conversion
$194.8K
Bode John B39,200 shares @ $4.97
Filed 2026-03-26Trade 2026-03-24
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.